Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic.

about

Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic.

Item

http://www.wikidata.org/entity/Q43421983

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Clinical audit: virological an ...... a Sydney sexual health clinic.

@en

Clinical audit: virological an ...... a Sydney sexual health clinic.

@nl

type

Item

label

Clinical audit: virological an ...... a Sydney sexual health clinic.

@en

Clinical audit: virological an ...... a Sydney sexual health clinic.

@nl

prefLabel

Clinical audit: virological an ...... a Sydney sexual health clinic.

@en

Clinical audit: virological an ...... a Sydney sexual health clinic.

@nl

P1476

Clinical audit: virological an ...... a Sydney sexual health clinic.

@en

P2093

D C Hsu

http://www.w3.org/2001/XMLSchema#string

J W Quin

http://www.w3.org/2001/XMLSchema#string

P2860

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.

Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.

A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts.

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.

Mean cell volume (MCV) changes in HIV-positive patients taking nucleoside reverse transcriptase inhibitors (NRTIs): a surrogate marker for adherence.

Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

CD4 cell count response to nonnucleoside reverse transcriptase inhibitor- or protease inhibitor-based highly active antiretroviral therapy in an observational cohort study.

P304

265-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1445-5994.2009.01983.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19460050

http://www.w3.org/2001/XMLSchema#string

P921

virology